| Literature DB >> 31382915 |
Jiehong Huang1, Zhihua Qiu1, Piansi Zhou1, Jianming Li1, Yingxin Chen1, Ruiyun Huang1, Chujing Li1, Xilin Ouyang1, Huazhuo Feng1, Hanqing Xu1, Dezhi Liu2, Zheng Dai3, Juehua Zhu4, Xinfeng Liu5, Hongbing Chen6, Yongjun Jiang7.
Abstract
BACKGROUND: The topographic location of acute pontine infarction is associated with clinical syndromes and prognosis. Previous studies focused on isolated pontine infarction, but the topographic location of unisolated pontine infarction has remained unclear.Entities:
Keywords: And topographic location; Isolated pontine infarction; Pontine infarction; Stroke; Unisolated pontine infarction
Mesh:
Year: 2019 PMID: 31382915 PMCID: PMC6681487 DOI: 10.1186/s12883-019-1411-6
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Fig. 1Topographic location of pontine infarction. There were 5 subtypes of pontine infarction: anteromedial, anterolateral, tegmental, bilateral and unilateral multiple pontine infarctions
Fig. 2Mechanism of pontine infarction. a LAD and (b) MRA of LAD with significant BA stenosis; (c) BABD and (d) MRA; (e) SAD and (f) MRA
Fig. 3Flow diagram
Baseline characteristics
| Characteristics | Isolated pontine infarction | Unisolated pontine infarction |
|
|---|---|---|---|
| Number | 673 | 330 | |
| Age (yrs) | 62.7 ± 13.1 | 62.6 ± 13.4 | 0.947 |
| Male | 60.1% | 63.6% | 0.291 |
| Hypertension | 79.9% | 78.5% | 0.592 |
| Diabetes | 37.3% | 36.7% | 0.846 |
| CHD | 8.8% | 11.2% | 0.216 |
| AF | 3.0% | 7.6% | 0.001 |
| High TG | 38.8% | 32.1% | 0.040 |
| High TC | 40.5% | 30.6% | 0.002 |
| High LDL | 30.2% | 24.8% | 0.079 |
| Uric acid | 19.3% | 20.6% | 0.630 |
| Smoker | 28.7% | 31.2% | 0.408 |
| Drinker | 18.7% | 17.6% | 0.659 |
| Medication | |||
| Antihypertensive | 63.3% | 62.1% | 0.717 |
| Hypoglycemic | 35.2% | 33.3% | 0.556 |
| Statins | 71.6% | 71.2% | 0.893 |
| Antiplatelet | 0.219 | ||
| ASA | 47.1% | 53.0% | 0.085 |
| Clo | 36.4% | 31.8% | 0.152 |
| DAPT | 16.3% | 15.2% | 0.691 |
| Anticoagulation | 6.7% | 8.2% | 0.389 |
| Previous stroke or TIA | 25.0% | 23.9% | 0.724 |
| Previous pontine infarction | 16.9% | 18.5% | 0.544 |
| NIHSS | 5.34 ± 3.16 | 5.34 ± 3.59 | 0.992 |
| BA stenosis | 44.8% | 44.5% | 0.922 |
| Topographic location | < 0.001 | ||
| Anterolateral | 19.8% | 19.7% | 0.981 |
| Anteromedial | 44.9% | 30.3% | < 0.001 |
| Tegmental | 16.0% | 24.5% | 0.001 |
| Bilateral | 13.1% | 15.2% | 0.370 |
| Unilateral multiple | 6.2% | 10.3% | 0.022 |
| Mechanism | < 0.001 | ||
| LAD | 16.5% | 24.5% | 0.002 |
| BABD | 49.2% | 32.4% | < 0.001 |
| SAD | 34.3% | 43.0% | 0.007 |
CHD coronary heart disease, AF atrial fibrillation, TG triglyceride, TC total cholesterol, LDL low density lipoprotein, ASA aspirin, Clo clopidogrel, DAPT dual antiplatelet therapy, TIA transient ischemic attack, NIHSS The National Institutes of Health Stroke Scale, BA basilar artery, LAD large artery disease, BABD basilar artery branch disease; SAD, small artery disease
Topographic location of pontine infarction
| Topographic location | LAD | BABD | SAD |
|---|---|---|---|
| Anterolateral | 32 | 63 | 103 |
| Anteromedial | 78 | 250 | 74 |
| Tegmental | 26 | 0 | 163 |
| Bilateral | 32 | 80 | 26 |
| Unilateral multiple | 24 | 44 | 8 |